Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 10/20 | 0.79 |
| ▸ | SSTR2 | P30874 | 15/20 | 0.76 |
| ▸ | SSTR5 | P35346 | 11/20 | 0.76 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.75 |
| ▸ | SSTR1 | P30872 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29360979 | 0.97 | SSTR4 (0.78) | SSTR4SSTR2SSTR5SSTR3SSTR1 | |
| SCHEMBL29414558 | 0.97 | SSTR4 (0.83) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL1651014 | 0.97 | SSTR4 (0.83) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL180440 | 0.97 | SSTR4 (0.83) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL29449384 | 0.97 | SSTR4 (0.82) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL5069978 | 0.97 | SSTR4 (0.82) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL29653935 | 0.92 | SSTR2 (0.79) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL23482744 | 0.89 | SSTR2 (0.88) | SSTR4SSTR2SSTR5SSTR3SSTR1 | |
| SCHEMBL23901126 | 0.89 | SSTR2 (0.88) | SSTR4SSTR2SSTR5SSTR3SSTR1 | |
| SCHEMBL24064978 | 0.88 | SSTR2 (0.83) | SSTR4SSTR2SSTR5SSTR3SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965751-B1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | ITM ISOTOPE TECH MUNICH SE (DE) | 2022-12-28 | — | — | EP | claimed |
| US-12605447-B2 | Stable formulations for radionuclide complexes | ITM SOLUCIN GMBH (DE) | 2026-04-21 | — | — | US | disclosed |
| US-20260069726-A1 | ZWITTERIONIC COMPOUNDS AND USES THEREOF | UNIV SASKATCHEWAN (CA) | 2026-03-12 | — | — | US | disclosed |
| US-20250345468-A1 | COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER | ITM ISOTOPE TECH MUNICH SE (DE) | 2025-11-13 | — | — | US | disclosed |
| EP-4615169-A2 | SYNTHESIS SYTEM COMPRISING A SOLUTION TARGET FOR CYCLOTRON PRODUCTION OF RADIOMETALS AND ASSOCIATED METHOD | Mayo Foundation for Medical Education and Research (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-3142709-B1 | SYNTHESIS SYTEM COMPRISING A SOLUTION TARGET FOR CYCLOTRON PRODUCTION OF RADIOMETALS AND ASSOCIATED METHOD | MAYO FOUND MEDICAL EDUCATION & RES (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20250170243-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2025-05-29 | — | — | US | disclosed |
| EP-4514405-A1 | COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER | ITM Isotope Technologies Munich SE (DE) | 2025-03-05 | — | — | EP | disclosed |
| US-20240374732-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2024-11-14 | — | — | US | disclosed |
| US-20240366812-A1 | Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive Cancer | ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA (CH) | 2024-11-07 | — | — | US | disclosed |
| EP-4065176-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotope Technologies Munich SE (DE) | 2022-10-05 | — | — | EP | disclosed |
| US-20220304964-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2022-09-29 | — | — | US | disclosed |
| US-11417439-B2 | Rapid isolation of cyclotron-produced gallium-68 | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2022-08-16 | — | — | US | disclosed |
| WO-2022112323-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM SOLUCIN GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022111800-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM SOLUCIN GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022099420-A1 | CYCLOTRON TARGET AND LANTHANUM THERANOSTIC PAIR FOR NUCLEAR MEDICINE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-05-19 | — | — | WO | disclosed |
| WO-2022096673-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotopen Technologien München AG (DE) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096103-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotopen Technologien München AG (DE) | 2022-05-12 | — | — | WO | disclosed |
| US-20220143227-A1 | Method of Treatment of Neuroendocrine Tumors That Over-Express Somatostatatin Receptors | ADVANCED ACCELERATOR APPLICATIONS (FR) | 2022-05-12 | — | — | US | disclosed |
| CN-114126654-A | Para-aminohippuric acid (PAH) as a kidney protective substance | 同位素技术慕尼黑有限公司 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250345468-A1 | COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER | SSTR1, SSTR3, SSTR2 | SSTR4 5/4885SSTR2 3/4885SSTR5 4/4885 |
| US-12605447-B2 | Stable formulations for radionuclide complexes | EPOR, CD47, PRCP | SSTR4 42/4885SSTR2 15/4885SSTR5 14/4885 |
| US-20250170243-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | SLC40A1, SLC7A11, GYPA | SSTR4 1238/4885SSTR2 1096/4885SSTR5 416/4885 |
| US-20220304964-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | PAH, SLCO1B1, SLCO2B1 | SSTR4 1042/4885SSTR2 1216/4885SSTR5 695/4885 |
| US-20240366812-A1 | Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive Cancer | GRPR, GIPR, CCKBR | SSTR4 12/4885SSTR2 15/4885SSTR5 11/4885 |
| US-20240374732-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | SLC40A1, SLC7A11, GYPA | SSTR4 1246/4885SSTR2 1080/4885SSTR5 410/4885 |
| US-20260069726-A1 | ZWITTERIONIC COMPOUNDS AND USES THEREOF | CA13, SLCO2B1, SLCO2A1 | SSTR4 78/4885SSTR2 80/4885SSTR5 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.